A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution
Authors:
- Gayathri SubramanianGSGayathri Subramanian
- Harold V. CohenHCHarold V. Cohen
- Samuel Y.P. QuekSQSamuel Y.P. Quek
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 112 (6) , 744-753
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigmCellular and Molecular Life Sciences, 2010
- Update on Estrogens and the SkeletonThe Journal of Clinical Endocrinology & Metabolism, 2010
- Cellular and Molecular Mechanisms of Bone RemodelingJournal of Biological Chemistry, 2010
- Short-Term Bisphosphonate Therapy Could Ameliorate Osteonecrosis: A Complication in Childhood Hematologic MalignanciesCase Reports in Medicine, 2010
- The emerging field of osteoimmunologyImmunologic Research, 2009
- Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone ClubInternational Journal Of Clinical Practice, 2008
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Building bone to reverse osteoporosis and repair fracturesJournal of Clinical Investigation, 2008
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007